1751 - 1775 of 6230 Results
Title
Year
-
OPENTitle: Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 7Issue #: 4Start Page: 436End Page: 444Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2010.08.228Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3117084Citation Count: 133
- CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts2018OPENTitle: CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohortsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 11Start Page: 1470End Page: 1481Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2018.01.010Best OA location URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.jalz.2018.01.010Citation Count: 656
- Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies2017OPENTitle: Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodiesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 11Start Page: 1237End Page: 1250Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2017.03.001Citation Count: 29
- Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease2013OPENTitle: Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 11Start Page: 3282End Page: 3289Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awt247Best OA location URL: https://academic.oup.com/brain/article-pdf/136/11/3282/11138755/awt247.pdfCitation Count: 173
-
OPENTitle: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/ncomms1453Best OA location URL: https://www.nature.com/articles/ncomms1453.pdfCitation Count: 445
- Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation2015OPENTitle: Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms8314Best OA location URL: https://www.nature.com/articles/ncomms8314.pdfCitation Count: 280
-
OPENTitle: Analysis of Mitochondrial haemoglobin in Parkinson's disease brainJournal Name: MitochondrionPublisher: Elsevier BVVol: 29Issue #:Start Page: 45End Page: 52Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mito.2016.05.001Best OA location URL: https://doi.org/10.1016/j.mito.2016.05.001Citation Count: 26
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial2017OPENTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Citation Count: 690
-
OPENTitle: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 9Start Page: 2480End Page: 2492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awu179Best OA location URL: https://academic.oup.com/brain/article-pdf/137/9/2480/13798270/awu179.pdfCitation Count: 180
- Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)2016OPENTitle: Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 140Issue #: 2Start Page: 287End Page: 305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww307Best OA location URL: https://academic.oup.com/brain/article-pdf/140/2/287/24174630/aww307.pdfCitation Count: 152
- O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease2015OPENTitle: O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's diseaseJournal Name: Nature ChemistryPublisher: Springer Science and Business Media LLCVol: 7Issue #: 11Start Page: 913End Page: 920Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nchem.2361Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4618406Citation Count: 253
- Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotes2014OPENTitle: Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 6Start Page: 752End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.313Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4082726Citation Count: 191
-
OPENTitle: Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 3Start Page: e91190End Page: e91190Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0091190Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0091190&type=printableCitation Count: 30
-
OPENTitle: Mechanism and regulation of the Lys6-selective deubiquitinase USP30Journal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 11Start Page: 920End Page: 930Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nsmb.3475Best OA location URL: http://doi.org/10.1038/nsmb.3475Citation Count: 201
- A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia2013OPENTitle: A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystoniaJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 12Start Page: 1699End Page: 1707Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-013-1048-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-013-1048-3.pdfCitation Count: 65
- Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm2013OPENTitle: Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasmJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 9Start Page: 1345End Page: 1353Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-013-0998-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-013-0998-9.pdfCitation Count: 60
- Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase Parkin2014OPENTitle: Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase ParkinJournal Name: PLoS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 10Issue #: 11Start Page: e1003935End Page: e1003935Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1003935Best OA location URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1003935&type=printableCitation Count: 106
-
OPENTitle: Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0051-5Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-017-0051-5Citation Count: 87
- Striatal Amyloid Plaque Density Predicts Braak Neurofibrillary Stage and Clinicopathological Alzheimer's Disease: Implications for Amyloid Imaging2012OPENTitle: Striatal Amyloid Plaque Density Predicts Braak Neurofibrillary Stage and Clinicopathological Alzheimer's Disease: Implications for Amyloid ImagingJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 28Issue #: 4Start Page: 869End Page: 876Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-111340Citation Count: 70
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions2010OPENTitle: Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusionsJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 42Issue #: 3Start Page: 234End Page: 239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ng.536Best OA location URL: https://research.vu.nl/en/publications/84f83b44-8218-449b-8492-6fc07730d692Citation Count: 553
- Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology2021OPENTitle: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathologyJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 47Issue #: 7Start Page: 1080End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12728Citation Count: 30
-
OPENTitle: Heterogeneity of Cholinergic Denervation in Parkinson's Disease without DementiaJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 32Issue #: 8Start Page: 1609End Page: 1617Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/jcbfm.2012.60Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2012.60Citation Count: 174
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study2015OPENTitle: Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 138Issue #: 4Start Page: 963End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awu409Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/148083964/Eltoprazine_counteracts_L_DOPA_induced_SVENNINGSSON_Publishedonline5February2015_GOLD_VoR_CC_BY_NC_.pdfCitation Count: 152
-
OPENTitle: (Patho‐)physiological relevance of PINK 1‐dependent ubiquitin phosphorylationJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 9Start Page: 1114End Page: 1130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201540514Best OA location URL: http://doi.org/10.15252/embr.201540514Citation Count: 165
- Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease Neuropathology2011OPENTitle: Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease NeuropathologyJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 4Start Page: 547End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2011.00557.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3639011Citation Count: 146